Considering the results of the present study and those reported in the literature, it has been demonstrated that there is a possibility to use SUDOSCAN as a supportive screening method in CKD in patients with type 2 diabetes, only if other co-factors are considered apart from EGFR (e.g., age, BMI, diabetes duration). This evidence concerns the gene EGFR and chronic kidney disease.